This study examined trends in the use of biologics for IBD, relative market share compared to other medication classes, and costs in the USA during a 9-year period.
Alimentary Pharmacology & Therapeutics
Original Article: Market Share, Costs of Biologic Therapies for IBD in the USA
NEXT ARTICLE